Daniel Weiner is a biotechnology entrepreneur and systems-level innovator working at the intersection of genetics, molecular engineering, artificial intelligence, and computational biology. He is Founder and CEO of GeneOS and HYJOURNAL, and CEO of Pure Peptides and MicroPharma. His background began in high-performance athletics, including competing at the national level, contributing to national championship teams, high-level bodybuilding, and nearly two decades of coaching. That performance-driven mindset evolved into studying biological systems, molecular pathways, and precision health.